Sapacitabine
Sapacitabine is a drug undergoing research for potential use in chemotherapy.
Sapacitabine is an oral nucleoside analog prodrug that acts through a dual mechanism. The compound interferes with DNA synthesis by causing single-strand DNA breaks and induces arrest of the cell division cycle at G2 phase.